RMNI vs SRPT · P/E 12, rev $216.5M vs rev $1.13B
Rimini Street Inc (RMNI) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Rimini Street Inc (RMNI) is a software - application company listed on NASDAQ.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported RMNI revenue for 2026-06-30 was $216.5M. Net income was $3.8M. RMNI currently screens at market cap $385.5M and trailing P/E 11.6.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
RMNI currently screens at market cap $385.5M and trailing P/E 11.6. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the RMNI and SRPT stock pages for the full models.
Not investment advice.